Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06702917 · ClinicalTrials.gov registry record
GSI Cardiac on Revolution Apex - US
A clinical trial of Cardiac Catheterization and Myocardial Infarction (MI), sponsored by GE Healthcare.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT06702917: Recruiting study of Cardiac Catheterization and Myocardial Infarction (MI), sponsored by GE Healthcare.
NCT06702917 is a study of Cardiac Catheterization and Myocardial Infarction (MI) that is actively recruiting participants, run by GE Healthcare. The registered enrollment target is 50 participants, below the 224-participant average among 6 other Cardiac Catheterization trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06702917, a study of Cardiac Catheterization and Myocardial Infarction (MI), is actively recruiting participants, sponsored by GE Healthcare.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical data collection study is to collect raw CT scan data using a new GSI Cardiac mode on GE HealthCare's Revolution Apex CT system. Two groups of participants will be enrolled: A) Participants scheduled to undergo a Coronary CT Angiography (CCTA) as part of their standard of care B) Participants scheduled to undergo a cardiac catheterization or have a history of heart attack Participants in Group A will: -Have a standard of care CCTA immediately followed by a research GSI Cardiac scan Participants in Group B will: -Have a research CCTA immediately followed by a research GSI Cardiac scan Both groups will be in the study for approximately 1 day. There are no follow-up visits after the day of scan.
Primary Outcome
Number of participants whose GSI Cardiac scan is deemed evaluable (i.e., no issues with participant motion or contrast administration and/or timing).
Conditions Studied
Interventions
- DEVICE GSI Cardiac Scan
- OTHER Standard of Care CCTA
- OTHER Research CCTA
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-09-10 |
| Est. Completion | 2026-03 |
What NCT06702917 shows while recruiting
NCT06702917 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 224-participant average among 6 other Cardiac Catheterization trials with a reported enrollment target (78% lower).
The record links to 3 conditions, with Cardiac Catheterization appearing as the primary indexed condition, and to 3 interventions - of which GSI Cardiac Scan is the first listed.
NCT06702917 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT06702917 about?
NCT06702917 is a clinical study titled "GSI Cardiac on Revolution Apex - US". The goal of this clinical data collection study is to collect raw CT scan data using a new GSI Cardiac mode on GE HealthCare's Revolution Apex CT system. Two groups of participants will be enrolled: A) Participants scheduled to undergo a Coronary CT Angiography (CCTA) as part of their standard of ...
What is the current status of trial NCT06702917?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2025-09-10. Estimated completion is 2026-03.
What conditions does trial NCT06702917 study?
This clinical trial studies the following conditions: Cardiac Catheterization, Myocardial Infarction (MI), Coronary Computed Tomographic Angiography.
What interventions are being tested in trial NCT06702917?
The interventions under investigation include: GSI Cardiac Scan (DEVICE), Standard of Care CCTA (OTHER), Research CCTA (OTHER).
Who is sponsoring clinical trial NCT06702917?
This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06702917 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Catheterization
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ultrasound-detectable Endotracheal Tube: a Feasibility Study
RECRUITING · NA
-
Post Anesthesia Care Unit (PACU) Weighted Blanket Study
COMPLETED · NA
-
Noninvasive, Subharmonic Intra-Cardiac Pressure Measurement
COMPLETED · Phase 2
-
Reduce Radiation Exposure in Fluoroscopic Interventions Evaluation
COMPLETED · NA
-
Femoral Arterial Access With Ultrasound Trial
COMPLETED · NA
-
Transatrial Pericardial Separation to Enhance Safety of Subxiphoid Pericardial Access for Left Atrial Appendage Ligation
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI